- Home
- COCH vs RDI Comparison
COCH vs RDI Comparison
Compare COCH & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- RDI
- Stock Information
- Founded
- COCH 1995
- RDI 1937
- Country
- COCH United States
- RDI United States
- Employees
- COCH N/A
- RDI N/A
- Industry
- COCH Blank Checks
- RDI Movies/Entertainment
- Sector
- COCH Finance
- RDI Consumer Discretionary
- Exchange
- COCH Nasdaq
- RDI Nasdaq
- Market Cap
- COCH 31.6M
- RDI 27.9M
- IPO Year
- COCH N/A
- RDI N/A
- Fundamental
- Price
- COCH $1.64
- RDI $1.34
- Analyst Decision
- COCH Strong Buy
- RDI Hold
- Analyst Count
- COCH 2
- RDI 1
- Target Price
- COCH $9.25
- RDI $2.40
- AVG Volume (30 Days)
- COCH 26.4K
- RDI 30.0K
- Earning Date
- COCH 08-11-2025
- RDI 08-13-2025
- Dividend Yield
- COCH N/A
- RDI N/A
- EPS Growth
- COCH N/A
- RDI N/A
- EPS
- COCH N/A
- RDI N/A
- Revenue
- COCH $212,000.00
- RDI $205,644,000.00
- Revenue This Year
- COCH $5.93
- RDI $7.47
- Revenue Next Year
- COCH $17.69
- RDI $13.22
- P/E Ratio
- COCH N/A
- RDI N/A
- Revenue Growth
- COCH N/A
- RDI N/A
- 52 Week Low
- COCH $1.21
- RDI $1.17
- 52 Week High
- COCH $3.99
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- COCH 60.61
- RDI 48.07
- Support Level
- COCH $1.43
- RDI $1.24
- Resistance Level
- COCH $1.59
- RDI $1.34
- Average True Range (ATR)
- COCH 0.11
- RDI 0.06
- MACD
- COCH 0.02
- RDI 0.00
- Stochastic Oscillator
- COCH 82.76
- RDI 52.63
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.